Profile data is unavailable for this security.
About the company
KDA Group Inc. is a Canada-based company focused on the development and marketing of its technological products and specialized software solutions for the healthcare market. The Company operates through Pharmaceutical Technology segment. It is focused on developing its technological products across four different platforms: KRX Medical, KRX Dental, KRX Cannabinoid and Adherize (ADRX). The KRX Dental is an electronic prescription platform assisting dentists in their practice. The KRX Medical is an electronic prescription platform assisting physicians in their practice. The KRX Cannabinoid is an electronic prescription platform assisting physicians in their practice when prescribing medical cannabis. The ADRX platform offers content allowing healthcare professionals (doctors and pharmacists) to virtually present various information. The platform includes various modules: Intelligent dialogue system, online questionnaire, pharmacist dashboard, developed algorithms, and a patient portal.
- Revenue in CAD (TTM)204.14k
- Net income in CAD-876.18k
- Incorporated2008
- Employees--
- LocationKDA Group IncBureau 300, 1351, rue Notre-Dame EstTHETFORD MINES G6G 0G5CanadaCAN
- Phone+1 (514) 715-0376
- Fax+1 (418) 755-0822
- Websitehttp://www.alliancepharma.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thiogenesis Therapeutics Corp | 0.00 | -4.49m | 30.94m | -- | -- | 6.51 | -- | -- | -0.1092 | -0.1092 | 0.00 | 0.1045 | 0.00 | -- | -- | -- | -91.94 | -- | -98.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Nurexone Biologic Inc | 0.00 | -5.62m | 37.67m | 8.00 | -- | 10.74 | -- | -- | -0.1081 | -0.1081 | 0.00 | 0.052 | 0.00 | -- | -- | -- | -183.97 | -213.78 | -235.34 | -596.97 | -- | -- | -- | -- | -- | -187.27 | 0.0096 | -- | -- | -- | 55.45 | -- | -- | -- |
| Avicanna Inc | 24.87m | -7.44m | 40.62m | 38.00 | -- | 1,130.84 | -- | 1.63 | -0.0804 | -0.0804 | 0.2714 | 0.0003 | 1.20 | 2.95 | 9.32 | 654,600.00 | -35.85 | -67.17 | -267.70 | -167.73 | 48.66 | 46.36 | -29.90 | -368.82 | 0.3316 | -8.88 | 0.1645 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
| Microbix Biosystems Inc | 23.36m | 5.08m | 47.07m | 69.00 | 9.34 | 1.68 | 7.13 | 2.01 | 0.0369 | 0.0369 | 0.1695 | 0.205 | 0.6488 | 1.63 | 6.35 | -- | 14.10 | -0.9729 | 16.10 | -1.17 | 57.21 | 52.30 | 21.73 | -1.55 | 4.89 | 5.93 | 0.1849 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
| KDA Group Inc | 204.14k | -876.18k | 48.26m | -- | -- | 3.35 | -- | 236.42 | -0.0027 | 0.0783 | 0.0013 | 0.0821 | 0.008 | -- | 0.0835 | -- | -4.63 | -17.96 | -8.47 | -44.69 | 33.32 | 26.76 | -574.97 | -28.00 | -- | -7.08 | 0.0606 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
| MustGrow Biologics Corp | 4.71m | -423.96k | 52.14m | 0.00 | -- | 14.47 | -- | 11.07 | -0.0078 | -0.0078 | 0.0927 | 0.0726 | 0.9337 | -- | 32.60 | -- | -8.40 | -50.41 | -11.41 | -59.28 | -- | -- | -9.00 | -298.73 | 4.84 | -- | 0.1215 | -- | 72,619.13 | 372.54 | 87.84 | -- | -- | -- |
| Satellos Bioscience Inc | 0.00 | -23.05m | 55.30m | 12.00 | -- | 1.90 | -- | -- | -0.2044 | -0.2044 | 0.00 | 0.2585 | 0.00 | -- | -- | 0.00 | -53.45 | -107.22 | -57.45 | -136.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.33 | -- | 459.46 | -- |
| Helix Biopharma Corp. | 0.00 | -6.14m | 63.24m | 9.00 | -- | -- | -- | -- | -0.1478 | -0.1478 | 0.00 | -0.0079 | 0.00 | -- | -- | 0.00 | -449.73 | -261.49 | -2,225.00 | -- | -- | -- | -- | -- | -- | -265.96 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |
| ZYUS Life Sciences Corp | 428.00k | -36.83m | 68.41m | 2.00 | -- | 4.20 | -- | 159.83 | -0.5247 | -0.5247 | 0.0061 | 0.2192 | 0.0074 | 0.075 | 0.5757 | -- | -63.34 | -57.88 | -88.37 | -71.19 | 46.50 | -16.16 | -8,604.67 | -10,367.37 | 0.1593 | -35.94 | 0.3955 | -- | 17.79 | 213.99 | -72.73 | -- | -- | -- |
